ENDP - Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg
- Endo International ( NASDAQ: ENDP ) creditors are looking at putting the pharma company up for sale through a bankruptcy, likely through a Chapter 11 filing in New York, Bloomberg reported.
- Endo ( ENDP ) has a debt load of more than $8B and is still facing many lawsuits over its alleged role in the nation's opioid epidemic.
- A bankruptcy filing would make it easier for Endo ( ENDP ) to make deals with with governments and other entities suing the company.
- Bloomberg said that some first-lien lenders are competing to use their debt holdings toward a bid for the company’s assets.
- Seeking Alpha contributor CashFlow Hunter, which has a strong sell rating on Endo ( ENDP ), has said a bankruptcy filing is imminent .
For further details see:
Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg